Research output

  1. Efficacy and Safety of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia: Phase 3, Multinational Open-Label Study

    Research output: Contribution to journal › Article › Academic › peer-review

  2. Vascular access for lipid apheresis: a challenge in young children with homozygous familial hypercholesterolemia

    Research output: Contribution to journal › Article › Academic › peer-review

  3. Paediatric patients with heterozygous familial hypercholesterolaemia treated with evolocumab for 80 weeks (HAUSER-OLE): a single-arm, multicentre, open-label extension of HAUSER-RCT

    Research output: Contribution to journal › Article › Academic › peer-review

View all (114) »

ID: 105486